Retrograde coronary venous ethanol ablation of ventricular tachycardia in a patient after aortic valve replacement and failed both radiofrequency ablation and stereotactic radiotherapy
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F23%3A00084193" target="_blank" >RIV/00023001:_____/23:00084193 - isvavai.cz</a>
Výsledek na webu
<a href="https://www.sciencedirect.com/science/article/pii/S221402712200183X" target="_blank" >https://www.sciencedirect.com/science/article/pii/S221402712200183X</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.hrcr.2022.09.009" target="_blank" >10.1016/j.hrcr.2022.09.009</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Retrograde coronary venous ethanol ablation of ventricular tachycardia in a patient after aortic valve replacement and failed both radiofrequency ablation and stereotactic radiotherapy
Popis výsledku v původním jazyce
Radiofrequency (RF) ablation is a well-established andfrequently used treatment modality for drug-refractory ventricular tachycardias (VT). The left ventricular (LV) summitrepresents a common site of origin of focal idiopathic VT.Less frequently, it can host the complex arrhythmogenic substrate in patients with structural heart disease such as dilatedcardiomyopathy or aortic valve disease. Such scenario mayrequire repeated ablation procedures with an uncertainoutcome. In the case of failed RF ablation, several unconventional treatment modalities, including bipolar RF ablation,stereotactic body radiation therapy (SBRT), and ethanol ablation, have been proposed. We report a case of successfulretrograde coronary venous ethanol ablation (RCVEA) ofVT in a patient after aortic valve replacement andpreviously failed both bipolar RF ablation and SBRT.
Název v anglickém jazyce
Retrograde coronary venous ethanol ablation of ventricular tachycardia in a patient after aortic valve replacement and failed both radiofrequency ablation and stereotactic radiotherapy
Popis výsledku anglicky
Radiofrequency (RF) ablation is a well-established andfrequently used treatment modality for drug-refractory ventricular tachycardias (VT). The left ventricular (LV) summitrepresents a common site of origin of focal idiopathic VT.Less frequently, it can host the complex arrhythmogenic substrate in patients with structural heart disease such as dilatedcardiomyopathy or aortic valve disease. Such scenario mayrequire repeated ablation procedures with an uncertainoutcome. In the case of failed RF ablation, several unconventional treatment modalities, including bipolar RF ablation,stereotactic body radiation therapy (SBRT), and ethanol ablation, have been proposed. We report a case of successfulretrograde coronary venous ethanol ablation (RCVEA) ofVT in a patient after aortic valve replacement andpreviously failed both bipolar RF ablation and SBRT.
Klasifikace
Druh
J<sub>SC</sub> - Článek v periodiku v databázi SCOPUS
CEP obor
—
OECD FORD obor
30201 - Cardiac and Cardiovascular systems
Návaznosti výsledku
Projekt
—
Návaznosti
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Ostatní
Rok uplatnění
2023
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
HeartRhythm case reports [online]
ISSN
2214-0271
e-ISSN
2214-0271
Svazek periodika
9
Číslo periodika v rámci svazku
1
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
4
Strana od-do
2-5
Kód UT WoS článku
—
EID výsledku v databázi Scopus
2-s2.0-85139363938